Bibliography
- BOWERS CY: GI-I releasing peptides - structure and ki-netics. J. Pediatr, Endocrinol. (1993) 6:21–31.
- •Lead publication in this field.
- BOWERS CY: Xenobiotic growth hormone secreta-gogues: growth hormone releasing peptides. Proceed-ings of the International Symposium of Growth Hormone Secretagogues. St. Petersburg, FL, USA (1996):9–28. Key review.
- SCHOEN WR, WYVRATT MJ, SMITH RG: Growth hormonesecretagogues. In: Annual Reports in Medicinal Chemistry. Bristol JA (Ed.), Academic Press (1993) 28:177-186. Key review.
- NARGUND R, VAN DER PLOEG LHT: Growth hormonesecretagogues. In: Annual Reports in Medicinal Chemistry. Bristol JA (Ed.) Academic Press (1997) 32:221–230
- •Key review.
- SMITH RG, CHENG K, SCHOEN WR et al.: A nonpeptidyl growth hormone secretagogue. Science (1993) 260:1640–1643.
- ••Lead publication in this field.
- SCHOEN WR, PISANO JM, PRENDERGAST K et al.: A novel 3-substituted benzazepinone growth hormone secreta- gogue (L-692,429). J. Med, Chem, (1994) 37:897–906.
- •Key secondary publication.
- WYVRATT M: Non-peptidyl growth hormone secreta- gogues. Proceedings of the International Symposium of Growth Hormone Secretagogues. St. Petersburg, FL, USA. (1996):103–117.
- •Key review.
- DEVITA RJ, WYVRATT MJ: Benzolactam growth hor- mone secretagogues. Drugs Fut. (1996) 21:273–281.
- •Key review.
- CHU L, MROZIK H, FISHER MH et al.: Aliphatic replace-ments of the biphenyl moiety of the non-peptidyl growth hormone secretagogues L-692,429 and L-692,585. Bioorg, Med. Chem. Lett. (1995) 5:2245–2250.
- DE VITA RJ, FRONTIER AJ, SCHOEN WR et al.: Design andsynthesis of potent macrocyclic growth hormone secretagogues. Helvetica Chimica Acta (1997) 80:1244–1258.
- OK HO, SZUMILOSKI JL, DOLDOURAS GA et al.: Benzolac-tam growth hormone secretagogues: replacement of the C-3 amide bond in L-692,429. Bioorg, Med. Chem. Lett. (1996) 6:3051–3056.
- ANKERSEN M, PESCHKE B, HANSEN BS, HANSEN TK: In-vestigation of bioisosters of the growth hormone secre-tagogue L-692,429. Bioorg, Med. Chem. Lett. (1997) 7:1293–1298.
- PATCHETT AA, WYVRATT MJ: The design of peptidomi-metic growth hormone secretagogues. In: Human Growth Hormone: Basic and Clinical Research. Smith RG, Thorner MO, Conn PM (Eds.), The Humana Press, Totowa, NJ, USA (1997). (In Press).
- •Key review.
- PATCHETT AA, NARGUND RP, TATA JR et al.:Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue. Proc. Natl. Acad. Sci, USA (1995) 92:7001–7005.
- ••Lead publication in this field.
- NARGUND RP, BARAKAT KH, CHENG K et al.: Synthesisand biological activities of camphor-based non-peptide growth hormone secretagogues. Bioorg, Med. Chem. Lett. (1996) 6:1265–1270.
- CHEN M-H, STEINER MG, PATCHETT AA et al.: Analoguesof the orally active growth hormone secretagogue L-162,752. Bioorg, Med. Chem. Lett. (1996) 6:2163–2168.
- TATA JR, NARGUND RP, MURPHY MM et al.: The synthesisand activity of spiroindane growth hormone secreta-gogues. Bioorg, Med. Chem. Lett. (1997) 7:663–668.
- CHAPMAN IM, BACH MA, VAN CAUTER E et al.: Stimula- tion of the growth hormone (GH/IGF-1) axis by daily administration of a Gil secretagogue (MK-0677) in healthy elderly subjects. J.EndocrinoL Metab, (1996)81:4249–4257.
- ••Lead publication in this field.
- CLEMMONS DR, PLUNKETT LI POLVINO WM: Admin-istration of the Gil secretagogue L-163,191 (MK-0677) stimulates an anabolic response in calorically re-stricted normal volunteers. Endo, Metab, (1997) 4 (Suppl. A):35. Abstract 0–066.
- •Key secondary publication.
- SVENSSON J, LONN L, JANSSON J et al.:Two months treat- ment of obese subjects with Gil secretagogue MK-677 increases fat-free mass and insulin-like growth factor 1 (IGF-1). Endo, Metab, (1997) 4 (Suppl. A) :35. Abstract 0–067.
- •Key secondary publication.
- MCDOWELL RS, ELIAS KA, STANLEY MS et al.: Growth hor-mone secretagogues: characterization, efficacy and minimal bioactive conformation. Proc, Nati, Acad, Sci, USA (1995) 92:11165–11169.
- LEFKER B, CARPINO P, GRIFFITH D et al.: The design, syn-thesis and biological activities of a series of tetrahydro-quinoline/isoindoline-based growth hormone secretagogues. 2nd International Symposium on Growth Hormone Secretagogues. Tampa, FL, USA (1997):P9 (Ab-stract).
- PONG S-S; CHAUNG L-Y, DEAN DC et al.: Identification of a new G-protein-linked receptor for growth hormone secretagogues. MoL EndocrinoL (1996) 10:57–61.
- ••Lead publication in this field.
- HOWARD AD, FEIGHNER SD, CULLY DF et al.: A receptor in the pituitary and hypothalamus that functions in growth hormone release. Science (1996) 273:974–977.
- ••Lead publication in this field.